Background CDK4 is highly expressed and associated with poor prognosis and decreased survival in advanced neuroblastoma (NB). Targeting CDK4 degradation presents a potentially promising therapeutic strategy compared to conventional CDK4 inhibitors. However. the autophagic degradation of the CDK4 protein and its anti-proliferation effect in NB cells has not been mentioned. https://www.campicon.com/